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Background: Sockeye Salmon are an iconic species widely distributed throughout the North Pacific. A devastating
pathogen of Sockeye Salmon is infectious hematopoietic necrosis virus (IHNV, genus Novirhabdovirus, family
Rhabdoviridae). It has been postulated that IHNV is maintained in salmon populations by persisting over the life of
its host and/or by residing in natural reservoirs other than its susceptible hosts. Herein we demonstrate the
presence of IHNV in the brain of Sockeye Salmon that survived an experimentally-induced outbreak, suggesting the
presence of viral persistence in this susceptible species. To understand the viral persistent state in Sockeye Salmon
we profiled the transcriptome to evaluate the host response in asymptomatic carriers and to determine what effects
(if any) IHNV exposure may have on subsequent virus challenges.
Results: A laboratory disease model to simulate a natural IHNV outbreak in Sockeye Salmon resulted in over a third
of the population incurring acute IHN disease and mortality during the first four months after initial exposure. Nine
months post IHNV exposure, despite the absence of disease and mortality, a small percentage (<4 %) of the
surviving population contained IHNV in brain. Transcriptome analysis in brain of asymptomatic virus carriers and
survivors without virus exhibited distinct transcriptional profiles in comparison to naïve fish. Characteristic for
carriers was the up-regulation of genes involved in antibody production and antigen presentation. In both carriers
and survivors a down-regulation of genes related to cholesterol biosynthesis, resembling an antiviral mechanism
observed in higher vertebrates was revealed along with differences in nervous system development. Moreover,
following challenge with poly(I:C), survivors and carriers displayed an elevated antiviral immune response in
comparison to naïve fish.
Conclusions: IHN virus persistence was identified in Sockeye Salmon where it elicited a unique brain transcriptome
profile suggesting an ongoing adaptive immune response. IHNV carriers remained uncompromised in mounting
efficient innate antiviral responses when exposed to a viral mimic. The capacity of IHNV to reside in asymptomatic
hosts supports a virus carrier hypothesis and if proven infectious, could have significant epidemiological
consequences towards maintaining and spreading IHNV among susceptible host populations.
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Sockeye Salmon (Oncorhynchus nerka), with their signa-
ture red spawning color, are an iconic species that is
widely distributed throughout the North Pacific having a
range that extends northwards from Oregon through
Canada to Alaska, USA and from Hokkaido Island,
Japan to Kamchatka Peninsula, Russia [1]. They are a
key component of marine and freshwater ecosystems,
and are highly valued as a food fish.
One of the most devastating pathogens of Sockeye
Salmon is infectious hematopoietic necrosis virus
(IHNV). The virus is enzootic throughout the range of
Sockeye Salmon where it can also infect trout and other
salmon species [2, 3]. IHNV is a negative-sense single-
stranded, enveloped RNA virus assigned into the genus
Novirhabdovirus within the family Rhabdoviridae [4]. First
described in Sockeye Salmon in the early 1950s [5, 6], infec-
tion with this virus may cause an acute systemic disease,
called infectious hematopoietic necrosis (IHN), with symp-
toms that may include lethargy, aberrant swimming, pe-
techiae (pinpoint bleedings) and ascites (fluid in the
peritoneal cavity) (reviewed in [7]). Outbreaks of IHN have
predominately occurred in pre-smolt stages (alevin and fry)
of Sockeye Salmon [8–11] although mortalities in smolts
has been documented [12–14]. In adult Sockeye Salmon,
the IHN virus is commonly found in spawning fish yet it is
not associated with disease [15, 16].
Due to the significance of IHN in salmon populations,
an extensive body of literature exists concerning the mo-
lecular characterization, pathogenesis, host response, and
vaccination of this virus (reviewed in [7]). However, key
questions regarding the epizootiology of IHNV remain
unresolved, such as how IHNV is maintained in wild
salmon populations. It has been suggested that adult
salmon get re-infected with IHNV from a marine or fresh-
water source during their spawning migration, and/or that
juveniles that survive virus exposure may become life-long
asymptomatic carriers of IHNV, with the virus reactivating
due to stress of the spawning migration [7].
Evidence in support of an asymptomatic IHNV carrier
state has been reported [17] yet detection of IHNV car-
riers has not been consistent across studies possibly due
to differences in the diagnostic methods used and the
tissues examined [18, 19]. LaPatra et al. [19] demon-
strated the presence of IHN virus in the brain of one out
of 30 rainbow trout (Oncorhynchus mykiss) surviving the
virus infection, however no virus was detected in kidney
tissue. More recently, we have identified juvenile Sockeye
Salmon in the marine environment that carry IHNV in
their brains (K.A. Garver and S.C. Johnson, unpub-
lished), however the consequences of these infections
are unknown.
Although viral carrier states, often referred to as viral
persistence, is well recognized and studied for a varietyof viruses of mammals [20–24] it has received much less
attention in lower vertebrate groups, including fish. Evi-
dence of persistence of fish viruses has been found for
infectious pancreatic necrosis virus (IPNV) [25], nodavirus
[26], koi herpesvirus (KHV) [27] and viral hemorrhagic
septicemia virus (VHSV) [28, 29]. However, knowledge of
how viral persistence is developed and maintained is very
limited, with some information available for nodavirus,
IPNV and KHV [30–33]. Furthermore, with the exception
of studies on nodavirus carriers in Atlantic cod (Gadus
morhua) [32], studies examining the consequences of per-
sistent viral infections in fish as they relate to the ability to
respond to subsequent pathogen exposure have been
limited.
Here we investigate the asymptomatic carrier state to
improve our understanding of persistent IHNV infections
in Sockeye Salmon populations, as well as explore the po-
tential consequences of the carrier state on subsequent
immune responses. Utilizing laboratory-controlled virus
exposures we identify viral persistence in asymptomatic
Sockeye Salmon nine months post challenge. We then
profile transcriptome differences between brain tissue ob-
tained from naïve (no virus exposure), survivors (exposed
to IHNV but tested negative for IHNV in brain), and car-
riers (exposed to IHNV and tested positive for IHNV in
brain). Additionally, for all groups a subset of individuals
were stimulated with the viral mimic polyriboinosinic
polyribocytidylic acid (poly(I:C)) to evaluate the effect of
the carrier status on subsequent immune responses. These
data are a first step in improving our understanding of
how and under what circumstances persistent infection
with IHNV occurs in Sockeye Salmon, and the potential
consequences of such infections.
Methods
Fish source and husbandry
In June 2011 Sockeye Salmon fry (Sakinaw Lake stock,
brood year 2010) were transferred from Rosewall Creek
hatchery, Fanny Bay, British Columbia (B.C.) to the Pacific
Biological Station (PBS), Nanaimo, B.C.. Fish were reared
in 5 °C (±1 °C) dechlorinated freshwater under a natural
photoperiod and fed dry pellets (EWOS) at 1 % body
weight per day. The source hatchery for the fish used in
this study has remained free of IHNV since its initiation of
Sockeye Salmon culture in 1999 (L. Clint, personal
communication) moreover viral screening a subset of 60
fish prior to transport to PBS, proved negative for the
presence of IHNV using cell culture assay [34].
Generation of IHNV survivors and carriers
In November 2011 Sockeye Salmon (600 fry, average
weight = 5.5 g) were immersed for one hour in a 85 L static,
aerated, 5 °C freshwater bath containing IHNV (Okanagan
2000 isolate, U genogroup; K.A. Garver, unpublished) at a
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was selected based on past challenge work in Sockeye
Salmon to initiate acute IHNV disease in the population
(K.A. Garver, unpublished). After the one hour exposure to
virus, the fish along with bath water were transferred into a
700 L tank. Sockeye Salmon from a separate tank that were
not handled or exposed to IHNV served as control
fish (naïve fish). Challenged and naïve fish were main-
tained in freshwater in one tank each, fed dry pellets
(EWOS), and monitored daily for signs of disease and
morbidity for a period of nine months. To mimic
temperature changes that would be normally experienced
in freshwater, fish were held for four months at 5 °C (±1 °
C) followed by a slow transition over several days to 9 °C
(±1 °C) for the remaining five months. At the end of the
study (nine months post challenge), naïve and surviving
Sockeye Salmon had similar average weights of 23 g and
20 g, respectively. All dead fish were individually bagged
and frozen at -80 °C for use in diagnostic testing. Dead
fish included moribund individuals that showed severe
lethargy or lack of swimming that were consequently eu-
thanized. To confirm presence of IHNV in mortalities
during the acute infection phase, anterior kidney of 16
dead fish collected between 19 and 138 days post challenge
(dpc) (Fig. 1) were examined using a cell culture plaque
assay following methods in [35]. An IHNV RT-rPCR withFig. 1 Cumulative mortality after IHNV challenge. Sockeye Salmon were expo
Randomly selected dead fish sampled between 19 and 138 days post cha
kidney by cell culture assay. Brains of surviving fish were screened by RT-r
virus-positive fish is denoted in parentheses and is calculated from the nu
(italicized numbers separated by a slash). The injection of poly(I:C) occurrespecific primers to the virus nucleocapsid gene was used to
evaluate viral persistence in survivors sampled at 195, 259,
274, 278 and 281 dpc. Use of research animals complied
with Fisheries and Oceans Canada Pacific Region Animal
Care Committee (AUP #11-024).Subsequent injection with polyriboinosinic
polyribocytidylic acid (poly(I:C))
At 271 dpc, 240 fish from each of the challenged and
naïve groups were reassigned into smaller 400 L tanks
(120 fish per tank; total of four tanks) supplied with the
same source of water. Shortly after the transfer, one group
each of the challenged and naïve fish received an intraper-
itoneal (ip) injection of poly(I:C) (Sigma-Aldrich) dis-
solved in saline solution at a dose of 10 μg per g fish, thus
the total amount of poly(I:C) was 200 and 230 μg for sur-
viving and naive fish, respectively. For controls, a group
each of challenged and naïve fish were transferred without
injection. A sample of 39 fish were removed from each
tank at 3 (274 dpc), 7 (278 dpc) and 10 (281 dpc) days
after poly(I:C) injection/transfer. At sampling fish were
euthanized in an overdose of buffered tricaine methane-
sulfonate (TMS) and brain and anterior kidney tissues
were aseptically removed, individually flash-frozen in
liquid N2 and transferred to −80 °C until RNA extraction.sed to waterborne IHNV (challenged fish) or left unhandled (naïve fish).
llenge (dpc) were tested for the presence of virus in the anterior
PCR for the presence of IHNV at indicated time points. The percent of
mber of positive detections out of the total number of fish tested
d at 271 dpc
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Samples of brain and anterior kidney were individually
homogenized in 1 ml TRIzol® (Life Technologies™) using
one stainless steel bead (5 mm, Qiagen) and a TissueLyser
II (Retsch Inc., Qiagen). Tissues were processed for 2 min
at 25 Hz at room temperature as per manufacturer’s in-
structions (Life Technologies™). Total RNA was extracted
following the TRIzol® protocol using 1-bromo-3-chloro-
propane in place of chloroform. An aliquot of each sample
was taken and reserved for IHNV diagnostic testing (see
below). The remaining sample was then purified by
treatment with DNase I using the RNase-Free DNase
Set (Qiagen) and subsequently column-purified using
the RNeasy® MinElute® Cleanup kit (Qiagen) following
manufacturer instructions. The RNA quantity and
quality of unpurified or purified extracts were deter-
mined by spectrophotometry (NanoDrop-1000) and
1 % agarose gel electrophoresis, then stored at −80 °C.
IHNV molecular diagnostic testing
Reverse transcriptase real-time PCR (RT-rPCR) was used to
screen the surviving fish for the presence of IHNV using
cycling conditions, probes, primers, and cut-off point as de-
scribed in [36]. Briefly, 2 μg unpurified total RNA was re-
verse transcribed to cDNA using High Capacity cDNA
reverse transcription kit (Applied Biosystems) with ran-
dom primers. Five μl of undiluted cDNA was added to
each RT-rPCR reaction in at least duplicate, and rPCR
screening tests were repeated to confirm positives.
For the purpose of this paper we refer to fish with
detectable IHNV in one or both tissues as “carriers”, while
“survivors” refers to fish in which IHNV was not detected.
The unexposed control fish are referred to as “naïve”.
Microarray preparation and data acquisition
Purified total RNA samples from brain were transcribed
to cDNA in a randomized order. From each sample,
200 ng total RNA was reverse transcribed to cDNA and
subsequently amplified to labeled cRNA using Low Input
Quick Amp Labeling kits (v6.5; Agilent Technologies) as
per manufacturer’s instructions. Experimental groups were
labeled with Cy5-CTP (Perkin Elmer) and these consisted
of naïve (n = 7), survivors (n = 7), and carriers (n = 5), as
well as poly(I:C)-injected naïve (n = 7), poly(I:C)-injected
survivors (n = 7), and poly(I:C)-injected carriers (n = 2).
All fish were sampled 274 dpc (i.e. three days after
poly(I:C) injection with the exception of two carriers that
were collected 278 dpc. The smaller sample size for car-
riers was a result of the few individuals that survived the
exposure that ended up carrying the virus.
A common reference design [37] was created by synthe-
sizing cRNA samples as described above but with Cy3-
labeled CTP for two individuals from each of the six
conditions (total in reference = 12 samples). Equimolarquantities of each of the conditions were pooled to create
the reference pool. Samples were hybridized to randomly
assigned cGRASP 4×44K salmonid arrays with previously
reported probe annotation [38–40] (Agilent Technologies,
AMADID: 025055) according to the manufacturer’s in-
structions. Slides were washed using the stabilization solu-
tion (Agilent Technologies) to prevent ozone degradation
of signal and were held in an environment that limited ex-
posure to ozone. Slides were scanned on a ScanArray®
Express (Perkin Elmer) at 5 μm resolution with constant
PMT settings (Cy5:75; Cy3:80) that had been optimized to
obtain 1 % of all spots saturated.
Images were quantified using Imagene 8.1 (Biodiscovery)
which allowed for spots of poor quality to be flagged. Back-
ground correction was performed by subtracting the me-
dian of the background signal from the median of the
foreground signal for each spot. The resulting files were
then imported to GeneSpring GX 11.5.1 (Agilent Tech-
nologies) for normalization and analysis, and after all
negative raw values being set to 1.0, the samples were nor-
malized by an intensity-dependent Lowess normalization
[41]. Data has been uploaded to GEO under accession
GSE65241. Probes were removed from the analysis if they
did not meet the following requirements in at least
65 % of the samples in any one condition: raw values ≥ 500
in both channels and no poor quality flags.
Transcriptome analysis
A two-way ANOVA (p ≤ 0.01; no multiple test correc-
tion) was performed in GeneSpring (Agilent) to identify
differentially expressed genes influenced by IHNV status
(naïve, survivor, or carrier), poly(I:C)-injection (control
or injected), or an interaction of both factors (Fig. 2).
Probes with a significant interaction effect were removed
from the main effect lists. Probes with a significant main
effect of IHNV status were additionally filtered by fold
change (FC), finding those probes with a 1.5-fold differ-
ence between survivor and control groups, or carrier
and control groups concurrently in both poly(I:C)
injected and non-injected groups. Genes specific to car-
riers or survivors were identified using a Venn diagram
of up- or down-regulated genes (Fig. 2).
Probes with a significant main effect of poly(I:C) injec-
tion were additionally filtered by fold change to identify
probes different between the poly(I:C)-injected and the
non-injected control groups (FC ≥ 1.5) consistently in all
of the following three comparisons: poly(I:C)-naïve vs.
non-injected-naïve; poly(I:C)-survivor vs. non-injected-
survivor; and poly(I:C)-carrier vs. non-injected-carrier.
Probes with a significant interaction between IHNV sta-
tus and poly(I:C)-injection were filtered by fold change to
retain probes that were differentially expressed by 1.5-fold
between any two groups. These probes were then used as
an input for a k-means clustering in GeneSpring (Agilent).
AB C
Fig. 2 Overview of microarray analysis in brain of Sockeye Salmon. a) A two-way ANOVA (p≤ 0.01) using expression data of the six groups naïve,
survivors, carriers with and without poly(I:C) injection was performed. The IHNV status is indicated for each group. All samples (n) were collected
3 d post injection, i.e. 274 d post challenge (dpc), except for 2 carriers that were sampled 278 dpc. b) Venn diagram of probes affected by IHNV
status, poly(I:C)-injection and interaction of both factors. Numbers in parentheses indicate numbers of probes retained after a fold change (FC)
cut-off of ≥ 1.5. One asterisk (*) indicates that all interaction probes were removed from main effect lists to analyze separately. Two asterisks (**)
refer to the number of probes used as input for k-means clustering shown in Fig. 3. c) Venn diagram of fold change-filtered up- and
down-regulated probes affected by IHNV status that were separated into survivor- and carrier-relevant probes
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GO FAT database in DAVID bioinformatics [42] using the
Entrez-ID terms associated with the probes, and a back-
ground list of 14184 probes passing quality control filters
(p-value cutoff). Venn diagrams were generated using
Venny [43].
Reverse transcriptase quantitative PCR
Reverse transcriptase quantitative PCR (RT-qPCR) was
used to validate the microarray data. For each brain sam-
ple used in the microarray analysis, first-strand cDNA was
synthesized from 400 ng of purified total RNA using the
High Capacity RNA-to-cDNA™ Kit (Applied Biosystems)
and 2.5 μM (final concentration) oligo d(T)16 primers
(Applied Biosystems) according to the manufacturer’s
instructions. Forward and reverse primers were de-
signed in Primer3 [44] and their sequences are given in
Additional file 1: Table S5.
Following cDNA synthesis, each 20 μl reaction was di-
luted 1:10 in nuclease-free water prior to use as templatefor RT-qPCR. Amplification was performed on a
Mx3000P (Agilent) in a 20 μl reaction that consisted of di-
luted cDNA, 0.3 μM each of forward and reverse primer
and 1X Power SYBR® Green PCR Master Mix (Applied
Biosystem). The cycling program consisted of 1 cycle of
50 °C for 20 s, 1 cycle of 95 °C for 10 min and 40 cycles of
95 °C for 15 s and 60 °C for 1 min. For each sample the
target transcript and reference gene were run in dupli-
cates. PCR amplicons were tested for single products by
melt curve analysis and sequenced on an ABI3130xL Gen-
etic Analyzer (Life Technologies™) to confirm identities as
per the manufacturer’s protocols using the RT-qPCR
primers and a fluorescent dye terminator cycle sequencing
kit (Applied Biosystems BigDye Terminator version 3.1).
Primer efficiencies were determined using a serial dilution
(2-fold, 5-point) of a pool of undiluted cDNA samples
from all experimental conditions.
Relative expression levels were calculated by using the
comparative Ct method for relative quantification includ-
ing primer-specific efficiencies [45]. Naïve fish served as a
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(LSM8) and dynein light chain 1 cytoplasmic (DYN) were
used as reference genes. The reference genes LSM8 and
DYN were selected due to their similar expression across
samples on the microarray and in RT-qPCR and recent
characterization as good reference genes for salmon [40].
To correlate results obtained by microarray and RT-
qPCR analysis, linear best fit lines of log2 expression
values for RT-qPCR samples versus microarray log2 ex-
pression ratios (Cy5/Cy3) were used for the probe corre-
sponding to the contig used for primer design.
Results
Generation of IHNV survivors and carriers
A waterborne IHNV challenge was utilized to generate
IHNV survivors and carriers. Mortality of IHNV-exposed
Sockeye Salmon fry began at 19 dpc and continued until
195 dpc resulting in cumulative mortality of 35.3 % (Fig. 1).
High mortality was observed during the initial four
months following IHNV exposure (19–120 dpc) and
accounted for over 92 % of the total mortality incurred
during the experiment. After this four month period, mor-
tality greatly subsided with only 17 mortalities occurring
over the subsequent two and a half months (120–195
dpc). Virological analysis of a subset of 16 diseased fish
collected between 19 and 138 dpc revealed the presence
of IHNV with titers ranging from 1.35 × 103 to 1.79 × 108
pfu/g (median 1.77 × 107 pfu/g). No mortality was ob-
served in the naïve (unhandled) group.
With the exception of a few fish that developed spinal
deformities such as scoliosis (sideways curvature) and/or
lordosis (inward curvature), the majority of the Sockeye
Salmon that survived appeared healthy and did not ex-
hibit any signs of disease or distress at nine months post
IHNV exposure. Using a highly sensitive IHNV RT-
rPCR assay [36], we tested over 200 of these survivors
for persistence of IHNV (Fig. 1). Although none of the
survivors tested positive for IHNV in their anterior kid-
neys, IHNV was detected in the brains of 45 % (9/20),
3.3 % (1/30) and 3.8 % (9/234) of the fish examined at
195, 259, and 274/278/281 dpc, respectively. In these
IHNV positive fish, the Ct-values ranged from 31 to 38.
IHNV was not detected in brain or anterior kidney tis-
sues of naïve fish (n = 10) sampled at 274 dpc that were
used in the microarray study.
Overview of microarray data
The response of Sockeye Salmon brain tissue to the
presence of IHNV and/or poly(I:C) injection was deter-
mined using samples collected at 3 days after poly(I:C)
injection (i.e. 274 dpc). Due to only three fish carry-
ing IHNV at 274 dpc, two carriers (no poly(I:C)
treatment) were also included from 278 dpc. This
enabled the analysis of probes affected by IHNVstatus, by poly(I:C)-injection or by an interaction of
the two factors (Fig. 2; Additional file 2: Table S1).
With respect to probes that were identified as being re-
sponsive in the brain to IHNV exposure alone, a compari-
son of naïve fish to IHNV-exposed fish (i.e. carriers and
survivors) identified more up-regulated probes than
down-regulated: 73 and 139 probes were up-regulated
among survivors and carriers, respectively, and only 25
and 42 probes were down-regulated. The majority (57 %)
of these differentially expressed probes were specific to
IHNV carriers while 21 % were specific to survivors, and
22 % were found in both carriers and survivors (Fig. 2).
With respect to probes that were identified as being re-
sponsive in the brain to poly(I:C) injection, poly(I:C)-in-
jection resulted in differential expression of 253 probes
(203 up-regulated and 50 down-regulated) relative to the
non-injected fish (Fig. 2). Notably, 31 probes had a
significant main effect of both IHNV status and
poly(I:C)-injection (Fig. 2). An interaction effect of
both factors was found for 162 additional probes
(Fig. 2). The following sections describe each of these
types of responses. Complete lists of probes and GO
enrichment analyses are shown in Additional files 3,
4 and 5 Tables S2, S3 and S4.
Probes significantly affected by IHNV status
Immune response
GO analysis revealed an enrichment of adaptive immune
responses in carriers relative to naïve fish (Additional
file 3: Table S2). Immunoglobulin-mediated immune re-
sponse (4 probes, p < 0.01) was enriched in IHNV carrier
fish due to increased expression of H-2 class II histocom-
patibility antigen gamma chain (CD74), complement C1q
subcomponent subunit B (C1QB) and complement C1s
subcomponent (C1S) relative to naïve fish (Additional file 3:
Table S2). Moreover, carrier-specific up-regulation of nu-
merous immunoglobulin (Ig) probes for various regions of
the light (n = 14) and heavy (n = 4) chains (FC from 1.9 to
9.8 (Table 1, Additional file 3: Table S2)) suggests an on-
going adaptive immune response in carriers. Antigen
processing and presentation of peptide antigen (3 probes,
p < 0.01) was significantly enriched by the carrier-
specific up-regulation of CD74 and tapasin (TAPBP).
Also involved in this biological process are cathepsin
S (CTSS), beta-2-microglobulin (B2M) as well as pro-
teasome subunit beta type-6 (PSMB6) and PSMB7
that were up-regulated in carriers relative to naïve fish. A
third enriched immune-relevant biological process was T
cell differentiation (3 probes, p < 0.05), but only two
unique annotations, CD74 and coronin-1A (CORO1A),
were associated with this function.
In contrast, survivors did not have any probes or GO
enrichment associated with antibody production, antigen
presentation or T cell differentiation, with the exception
Table 1 Fold changes of selected genes affected by IHNV status






Cell Proliferation GTP-binding nuclear protein Ran (RAN)** 1.6 to 2.2 1.5 to 1.8 1.8 to 1.9 1.5 to 1.8 
Homeostasis 
Plasma retinol-binding protein 1 (RBP1)** 2.8 1.6 - - 




Proteasome subunit beta type-6 (PSMB6) - - 1.7 3.6 
Proteasome subunit beta type-7 (PSMB7)** - - 1.7 2.6 
Beta-2-microglobulin(B2M) - - 1.5 to 1.8 1.9 to 2.6 
--)SSTC(SnispehtaC 1.6 to 2.1 2.0 to 2.5 
H-2 class II histocompatibility antigen 
--)47DC(niahcammag 1.6 to 2.4 2.1 to 3.7 
117849 pfam09307, CLIP, MHC II 
interacting 2.2 1.7 2.7 3.2 
--**)PBPAT(nisapaT 1.6 2.8 
Immune Response: 
Humoral Response 
--)@VKGI(niahcappakgI 1.9 to 6.0 2.0 to 5.9 




Allograft inflammatory factor 1 (AIF1) - - 1.8 2.2 
Annexin A5 (ANXA5) 1.9 1.5 - - 
CCAAT/enhancer-binding protein delta 
(CEBPD) 2.6 2 - - 
Complement C1q subcomponent subunit B 
(C1QB) - - 2.4 1.6 
Complement C1s subcomponent (C1S) - - 1.9 2.1 
fMet-Leu-Phe receptor (FPR1) - - 1.6 1.7 
Galectin-3-binding protein (LGALS3BP)*, 
** 2.6 to 3.5 2.4 to 2.7 2.0 to 2.1 2.5 to 2.8 
Interleukin-1 receptor-like 1 (IL1R1) -1.5 -1.7 -1.6 -1.6 
Latent-transforming growth factor beta-
binding protein 1 (LTBP1) -2.5 -3.1 -1.6 -1.8 
Lysozyme g (LYG) 1.7 to 2.3 1.5 to 1.9 1.7 to 2.2 1.6 to 2.1 
Pentraxin fusion protein (PXN1) 1.6 1.6 - - 
Peroxiredoxin (PRDX)** 1.7 to 2.3 1.7 to 1.9 - - 
--)1CAT(1-ninikyhcatorP 1.7 1.5 
Transient receptor potential cation channel 
subfamily V member 1 (TRPV1) - - 1.7 2.5 
Metabolism: 
Lipid Metabolism 
Diphosphomevalonate decarboxylase (MVD) -1.9 -2 - - 
Farnesyl pyrophosphate synthetase (FDPS) -1.6 -1.9 -1.6 to -1.5 -2.1 to -2.0 
GPI inositol-deacylase (PGAP1) - - 1.6 1.8 
Hydroxymethylglutaryl-CoA synthase, 
cytoplasmic (HMGCS1) -2.7 -2.9 -2.3 -2.9 
Lipoprotein lipase (LPL)** 1.6 1.6 1.5 1.5 
Phospholipase A1 member A (PLA1A) - - 2.1 1.5 
Proactivator polypeptide (PSAP) - - 2.3 2.4 
Sterol-4-alpha-carboxylate 3-dehydrogenase, 




Basic leucine zipper and W2 domain-
containing protein 2 (BZW2) 2 1.9 1.7 1.7 
Cocaine- and amphetamine-regulated 
transcript protein (CARTPT) - - 1.5 to 1.7 1.8 to 1.9 
Corticotropin-releasing factor-binding protein 
(CRHBP) - - 1.8 1.7 
COUP transcription factor 2 (NR2F2) - - 1.5 to 1.6 1.5 to 1.9 
Ependymin (EPD)** 1.8 1.6 1.5 to 2.7 1.6 to 1.9 
Ependymin-2 (EPD2)** 1.7 2.2 - - 
Glucocorticoid receptor DNA-binding factor 
--)53PAGHRA(1 1.6 1.8 
GPI inositol-deacylase (PGAP1) - - 1.6 1.8 
Homeobox protein orthopedia B (OTP) - - 2.3 2.1 
Integral membrane protein 2B (ITM2B) - - 1.6 1.6 to 1.7 
Myelin P0 protein (MPZ) -1.6 -1.5 - - 
Pro-Melanin-Concentrating Hormone 1 
(PMCH) 4.7 4.2 7 7.2 
Pro-Melanin-Concentrating Hormone 2 
(PMCH) 3.3 2.7 3.9 5.4 
--)2GCS(2-ninargoterceS 1.5 1.5 
Protein Processing: 
Translation 40S ribosomal protein S2 (RPS2)** 2.9 to 3.2 2.2 to 2.4 - - 
Protein Processing: 
Protein 
Modification Beta-1,3-glucosyltransferase (B3GALTL)** 2.0 to 3.6 1.7 to 2.1 - - 
Other 
Intermediate filament protein ON3** 1.9 1.8 - - 
Parvalbumin, thymic (PVALB)** 6.1 5.2 - - 
Solute carrier family 22 member 7 
(SLC22A7)** 1.9 1.6 - - 
Survivor- or carrier-relevant genes were obtained if fold changes were ≥1.5 between survivor (S) and naïve (N) fish or carrier (C) and naïve (N) fish concurrently in
both poly(I:C)-injected (pIC) and non-injected groups. The gene galectin-3-binding protein marked with one asterisk (*) has been described as virus responsive
gene (VRG) in Krasnov et al. [54]. Genes labeled with two asterisks (**) were also affected by main factor poly(I:C) injection (see Table 2). Colors refer to ranges of
fold changes: yellow 1.5 to 2.5; orange 2.6 to 3.5; brown 3.6 to 9.8. Light green −2.5 to −1.5; green −3.1 to −2.6
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heavy chains (FC = 1.6 to 1.9) and probe 117849
pfam09307 (FC = 1.7 to 2.2) that may interact with
major histocompatibility complex (MHC) class II mole-
cules to facilitate antigen presentation.
Relative to naïve fish, both carriers and survivors differen-
tially expressed genes involved in inflammation. While
carrier-specific probes included transient receptor potential
cation channel subfamily V member 1 (TRPV1), C1QB, C1S
and protachykinin-1 (TAC1), survivor-specific probes were
annexin A5 (ANXA5), CCAAT/enhancer-binding protein
delta (CEBPD) and peroxiredoxin (PRDX). While carrier-
specific probes contributed to the enrichment of the bio-
logical process inflammatory response (4 probes, p < 0.05),
no GO enrichment was identified among survivor-specific
probes. A few probes involved in innate immune responses,
including inflammation showed the same patterns of ex-
pression in both carriers and survivors relative to naïve fish.
These include galectin-3-binding protein (LGALS3BP) and
lysozyme g (LYG) which were up-regulated and interleukin-
1 receptor-like 1 (IL1R1) and latent-transforming growth
factor beta-binding protein-1 (LTBP1) which were down-
regulated. While these results indicate that innate immune
responses occur in both carriers and survivors, adaptive im-
mune responses take place only in carriers.
Lipid metabolism
Cholesterol is an essential component of cellular mem-
branes and regulation of cholesterol synthesis may inter-
fere with viral lifecycles [46]. In this study we identified
multiple genes involved in cholesterol biosynthesis [47,
48] that were significantly down-regulated in carriers
and survivors when compared to naïve fish (Table 1,
Additional file 3: Table S2). These included hydroxy-
methylglutaryl-CoA synthase cytoplasmic (HMGCS1)
and farnesyl pyrophosphate synthetase (FDPS) in both
survivors and carriers, diphosphomevalonate decarboxyl-
ase (MVD) in survivors, and sterol-4-alpha-carboxylate
3-dehydrogenase, decarboxylating (NSDHL) only in
carriers.
Genes with other roles in lipid metabolism had in-
creased levels of expression in the brains of carriers and
survivors when compared to naïve fish. Three carrier-
specific probes (FC ≤ 2.4) included GPI inositol-deacylase
(PGAP1), phospholipase A1 member A (PLA1A) and
proactivator polypeptide (PSAP). Lipoprotein lipase (LPL)
showed increased expression in both survivors (FC = 1.6)
and carriers (FC = 1.5).Nervous system development and function
Genes involved in the development and function of the
nervous system were also affected by IHNV exposure.
Twenty probes associated with this process weresignificantly up-regulated in carriers relative to naive
fish, whereas only 6 probes (5 up- and 1 down-
regulated) showed differentially expression in survivors
compared to naïve fish (Table 1, Additional file 3: Table
S2). GO enrichment analysis identified biological pro-
cesses such as forebrain development (4 probes, p < 0.01)
and behavior (5 probes, p < 0.05) only among carrier-
specific up-regulated probes, while no biological processes
were enriched among survivor-specific probes probably due
to the low number of probes in this group.
Both carriers and survivors showed significant up-
regulation of basic leucine zipper and W2 domain-
containing protein 2 (BZW2) which is possibly involved
in neuronal differentiation, as well as ependymin (EPD)
that may play a role in consolidation of memory and
regeneration of neurons. The probes with highest fold
changes related to nervous system function for both
survivors and carriers were pro-melanin-concentrating
hormone (PMCH) 1 and 2 (FC = 2.7 to 4.7 (survivors)
and 3.9 to 7.2 (carriers)), a neuropeptide regulating
body color and appetite in fish [49, 50]. Specific to sur-
vivors was the down-regulation of myelin P0 protein
(MPZ), which is a component of myelin sheaths, the
insulators of axons that facilitate efficient action po-
tential conduction. These results suggest that the
brain’s function may be affected in both carriers and
survivors.
Probes affected by poly(I:C)-injection
To determine whether a previous exposure to IHNV af-
fects how Sockeye respond to other immunological chal-
lenges, both naïve and surviving Sockeye (survivors and
carriers) were intraperitoneally injected with the viral
mimic poly(I:C) and sampled 3 dpi. Two hundred and
fifty three probes were identified that were affected by
poly(I:C) regardless of the IHNV status (i.e. main effect
of poly(I:C), no significant interaction effect) (Fig. 2).
Enriched among the 203 up-regulated probes were
GO categories response to virus (p < 0.01), antigen
processing and presentation (p < 0.01), immune re-
sponse (p < 0.01), defense response (p < 0.01) and cellular
protein catabolic process (p < 0.01) suggesting a character-
istic antiviral immune response in poly(I:C)-injected com-
pared to non-injected fish regardless of IHNV status
(Additional file 4: Table S3).
Viral RNA and poly(I:C) are detected by transmem-
brane and cytosolic pattern recognition receptors
(PRR) [51]. Expression of probable ATP-dependent
RNA helicase DDX58 (RIG-I), a cytosolic PRR, was sig-
nificantly up-regulated in poly(I:C)-injected Sockeye
Salmon (Table 2, Additional file 4: Table S3). Activa-
tion of RIG-I may induce the production of type I
interferon (IFN) mediated by signal transducers such
as IFN regulatory factor (IRF) 3 and IRF7 [51]. In the
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also up-regulated, as were several type I IFN-stimulated
genes including IFN-induced GTP-binding protein Mx,
IFN-induced protein 44, IFN-induced protein with
tetratricopeptide repeats 5, IFN-induced very large
GTPase1 and radical S-adenosyl methionine domain-
containing protein 2 (Vig1). Cellular responses to type I
IFN are mediated by the Janus kinase (JAK) and signal
transducer and activator of transcription (STAT) (JAK/
STAT) signaling pathway [52, 53]. Genes coding for
components of this pathway such as STAT1 and
STAT1-alpha/beta were up-regulated, indicating a role
of this pathway in response to the injection of poly(I:C).
Other up-regulated probes identified in poly(I:C)-
injected fish were sacsin (SACS) and galectin-9 that are
commonly reported as up-regulated after poly(I:C) or
virus treatment [54].
Other genes associated with immunity but not restricted
to the innate antiviral response were also induced in
poly(I:C)-injected fish (Table 2, Additional file 4: Table S3).
These include genes involved in antigen processing and
presentation such as antigen peptide transporter 1 and 2
(TAP1, TAP2), proteasome subunit beta type-8 (PSMB8)
and TAPBP. Cell chemotaxis was indicated by the up-
regulation of two probes annotated with 29114 cd01119,
Chemokine_CC_DCCL. There was also up-regulation of a
probe annotated as nicotinamide phosphoribosyltransferase
(NAMPT). This gene encodes a protein known to be in-
volved in nicotinamide adenine dinucleotide (NAD) biosyn-
thesis, but cytokine-like activity has also been reported for
this protein (reviewed in [55]). Some of the highest fold
changes (FC between 22.3 and 83.2) were found for probes
annotated as ubiquitin. The functions of ubiquitin include,
but are not limited to protein degradation, cell cycle, toll-
like receptor (TLR) signaling, apoptosis and mRNA
metabolism.
Also noteworthy is the up-regulation of several probes
that are annotated to non-immune related genes that
have been identified as viral responsive genes (VRG) by
Krasnov et al. [54]. These include deoxycytidine kinase
(DCK) that is required for nucleotide biosynthesis, and
poly [ADP-ribose] polymerase 12 (PARP12) that is in-
volved in protein modification. In addition, the VRG
receptor-transporting protein 3 (RTP3) showed strong
up-regulation (between 27.5 and 59.2) in poly(I:C)-
treated Sockeye Salmon, though its function in response
to viruses is mostly unknown [54].
Poly(I:C)-injection also resulted in down-regulation of 50
probes (Table 2, Additional file 4: Table S3). These include
probes associated with innate immune responses including
complement component C7 (C7), ANXA5, complement re-
ceptor type 2 (CR2) and lysozyme C II.
Common to both IHNV status and poly(I:C) injec-
tion (main effect lists) were 31 probes with 15 uniqueannotations (Additional files 3 and 4: Tables S2, S3).
Within this list were 11 genes that were up-regulated in
survivors and/or carriers, and down-regulated by poly(I:C)-
injection. These include beta-1,3-glucosyltransferase
(B3GALTL), PRDX, plasma retinol-binding protein 1
(RCP4A), EPD, ependymin-2 (EPD2) and serotransfer-
rin-2 (TF2-11). The remaining four genes (40S riboso-
mal protein S2 (RPS2), proteasome subunit beta type-7
(PSMB7), TAPBP, LGALS3BP) were up-regulated in
survivors and/or carriers, and also up-regulated in
poly(I:C)-injected fish, suggesting a general role of
these genes in host response to foreign RNA.
Probes affected by interaction of IHNV status and
poly(I:C) injection
Some probes responded to poly(I:C) differently de-
pending on the IHNV status of the group. These 162
probes were clustered by expression level for improved
characterization to generate four distinct clusters (I to
IV) with 18, 45, 41 and 58 probes, respectively (Fig. 3,
Additional file 5: Table S4).
Probes in cluster I had similar expression among non-
injected groups and up-regulation following poly(I:C)-in-
jection, with highest expression in survivors and carriers.
For some probes the highest expression was in injected
carriers (Fig. 3, Additional file 5: Table S4). Although
there were only ten uniquely annotated probes within
this cluster, this cluster was enriched for genes involved
in defense response (3 probes, p < 0.01) (Additional file 5:
Table S4), including N-myc-interactor (NMI) that aug-
ments cytokine-mediated STAT transcription, NF-kappa-B
inhibitor zeta (NFKBIZ) that is an inhibitor of NF-kappa-B
transcription factors which play critical roles in inflam-
mation, immunity, cell proliferation, differentiation
and survival, and probable ATP-dependent RNA heli-
case DHX58 (DHX58) which is another cytosolic PRR
to detect foreign RNA. This cluster also contained ster-
ile alpha motif domain-containing protein 9 (SAMD9)
that is involved in inflammatory responses to tissue in-
jury, and CXC chemokine that may have multiple func-
tions and may be involved in immune and homeostatic
functions. Within this cluster, fold changes of most
probes were similar in poly(I:C)-injected survivors and
poly(I:C)-injected carriers relative to the poly(I:C)-
injected naïve fish. An exception included probes (n = 4)
annotated as probable E3 ubiquitin-protein ligase
HERC4 that is involved in modification and degrad-
ation of proteins, for which injected survivors and
carriers were 2.4 to 2.6 fold and 5.4 to 9.2 fold, re-
spectively, up-regulated relative to injected naïve fish
(Fig. 3, Additional file 5: Table S4).
Cluster II was characterized by probes that showed
minor changes (FC < 2) in expression between naïve, sur-
vivors and carriers prior to and following poly(I:C)-
Table 2 Fold changes of selected genes affected by poly(I:C) injection
A probe was retained if fold changes were ≥1.5 in all three comparisons: poly(I:C)-injected naïve fish (N-pIC), survivors (S-pIC) or carriers (C-pIC) versus the
respective non-injected group (N, S, C). Genes marked with (*) have been described as virus responsive genes (VRG) in Krasnov et al [54]. Genes labeled with (**)
were also affected by main factor IHNV status (see Table 1). Colors refer to ranges of fold changes: yellow 1.5 to 2.5; orange 2.6 to 3.5; brown 3.6 to 10.0; red 10.1
and higher. Light green -2.5 to -1.5; green -3.5 to -2.6; dark green -3.6 and lower.
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cluded probes that varied in expression among non-
injected groups, and had a slight decreased expression in
injected groups (Fig. 3, Additional file 5: Table S4). In this
cluster, injected survivors were similar to injected naïve
fish, but several probes had lowest expression in injected
carriers (FC ≥ 2 relative to injected naïve fish). These in-
cluded probes with annotation to GTP-binding protein 10,
involved in ribosome biogenesis, cell division protein kin-
ase 4, involved in cell proliferation and prostaglandin E
synthase 3, associated with inflammation and lipid metab-
olism. One probe with the largest down-regulation was
nuclease-sensitive element-binding protein 1 (YBX1)
(FC = 23.4), which is involved in mRNA processing. Clus-
ter IV contained probes with similar expression in non-
injected fish. In injected fish, both carriers and survivors
showed small but significant increases in expression (Fig. 3,
Additional file 5: Table S4) and probes in injected naïve
fish remained similar to those in non-injected fish. Within
this cluster, enriched biological processes (p < 0.05) in-
cluded metabolic processes (polysaccharide metabolic
process (3 probes), sulfur metabolic process (3 probes),
chondroitin sulfate metabolic process (2 probes) and regu-
lation of RNA metabolic process (7 probes)) and negative
regulation of cell differentiation (3 probes) (Additional
file 5: Table S4).
Validation of the microarray results by RT-qPCR
To validate data obtained by microarray analysis RT-
qPCR was performed on 12 transcripts that were differ-
entially expressed in the microarray analysis. These
included MX, SACS, LGALS3BP, immunoglobulin μ
heavy chain (Ig HCmu), EPD2, CEBPD, RTP3, C7, C1S,
squalene monooxygenase (SQLE), FDPS and B3GALTL
(see Additional file 1: Table S5 for full gene names). Log2
expression ratios (Cy5/Cy3) of the microarray vs. log2 ex-
pression values of the RT-qPCR analysis were correlated
for each gene and individual as shown for MX in
Additional file 6: Figure S1a. R2 and slope values from the
best fit lines of these correlations are shown in Additional
file 6: Figure S1b. The median R2 is 0.7. These results indi-
cate that expression levels of the studied transcripts corre-
lated well between the microarray and RT-qPCR analysis.
An exception was B3GALTL whose expression change on
the array could not be confirmed by RT-qPCR as indi-
cated by its low R2 value of 0.2.
It was difficult to determine whether both secreted and
membrane-bound forms of Ig mu chain C region were
present on the array. Therefore we used primers specific-
ally designed to amplify either the secreted or the mem-
brane form of the Ig mu chain [56] by RT-qPCR. The
results indicated that both the membrane-bound and se-
creted forms of Ig mu chain were specifically up-regulated
in carriers. The probes best matching each of these sets ofprimers were highly correlated with their expression pro-
filed by RT-qPCR (membrane-bound probe C078R010, se-
creted probe C017R015; both R2 = 0.9).
Discussion
Generation of IHNV survivors and carriers
Infectious hematopoietic necrosis virus is distributed
widely on the Pacific Coast of Canada and the United
States where species such as Sockeye Salmon are com-
monly infected. Despite the relatively frequent occur-
rence of IHNV in salmon and trout, our understanding
of viral persistence after infection of these species re-
mains uncertain. Here we utilized a laboratory disease
model to simulate a natural IHNV outbreak in Sockeye
Salmon with the aim of better defining the relationship
between Sockeye Salmon and IHNV, whether the virus
persists within this host, and if so what are the conse-
quences of such infections.
To best simulate a natural virus infection, Sockeye
Salmon were waterborne exposed to an IHNV strain that
naturally occurs in Sockeye Salmon in British Columbia
[3]. Additionally, virus exposure was conducted under a
similar photoperiod and water temperature regime as ex-
perienced by the Sockeye Salmon in their natural rearing
environment. Our challenge initiated an IHNV disease
epizootic that resulted in 35.3 % cumulative mortality with
surviving fish remaining free of any signs of disease. How-
ever, among a small number of these survivors, spinal de-
formities such as scoliosis and lordosis were observed as
has been reported in other studies of IHNV surviving
salmonids [6, 19]. Although it was possible to maintain
these fish in a laboratory setting, it is extremely likely that
in a natural setting these individuals would be quickly re-
moved from the population due to their inability to
avoid predation. Consequently because these fish are
likely not sustained in the wild they were excluded
from our analyses.
The asymptomatic survivors of infection were screened
for the presence of IHNV in the brain and anterior kidney
and although kidney tissue typically contains high viral
loads during the acute stages of IHN disease [57], no virus
was detected in this tissue of surviving fish. Conversely,
IHNV was detected in brain tissue among these survivors,
demonstrating that tissues of the central nervous system
play an important role in IHNV persistence and substanti-
ates its neurotropic potential [58]. Interestingly, the pro-
portion of fish testing positive for IHNV in brain
decreased from a high of 45 % immediately following the
cessation of morbidity (195 dpc) to < 3.8 % at the time of
the initiation of the microarray study (274 and 278 dpc).
This declining viral persistence over time may be an indi-
cator of those individuals in the population which either
got infected later and/or simply retain virus longer than
the majority of the surviving population.
Fig. 3 Cluster analysis of probes affected by interaction of poly(I:C)-injection and IHNV status. Based on expression levels of individual probes,
clusters I to IV were generated containing 18, 45, 41 and 58 probes, respectively. Fold changes of uniquely annotated probes from cluster I are
shown for poly(I:C)-injected survivors (S-pIC) and carriers (C-pIC) relative to naïve-injected fish (N-pIC) (fish group abbreviations as defined in
Fig. 2). Colors refer to ranges of fold changes: yellow 1.5 to 2.5; orange 2.6 to 3.5; brown 3.6 to 9.2. Genes marked with an asterisk (*) have been
described as virus responsive genes (VRG) in Krasnov et al. [54]
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outcomes of viral infection of the nervous system, all
of which result in a host defense response. These are
acute replication, persistence and latency. They define
persistent viral infections as infections in which thevirus undergoes continuous viral replication while la-
tent infections are defined as a “dormant” state dur-
ing which replication is minimized or ceased. With
respect to IHNV, it is unclear what category the
asymptomatic carriers observed in our study would
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lack of virus in anterior kidney, it is unlikely that the
IHNV carrier fish represents an acute replication
stage. Typically during acute IHNV infections, when
high titers of virus are present systemically, fish ex-
hibit a strong antiviral immune response which can
include up-regulation of IRF1, IRF7, IFN-induced pro-
tein 44, IL-1β and Mx [60, 61]. However in the
asymptomatic carriers examined herein, such antiviral
responses were not present suggesting that viral repli-
cation is limited. As the prevalence of IHNV positive
fish decreased over time, it is possible that carriers
simply represent an earlier stage of recovery that
would eventually result in virus clearance or in re-
duced viral loads that are below detectable levels.
While clearly more work needs to be done to define
the infection status of those fish, in this study they
are referred to carriers or persistently infected fish
which is in accordance to the definition by Kane and
Golovkina [24]. Similar reductions in virus load have been
observed for other fish viruses such as KHV, nodavirus
and VHSV [29, 62–64] and sometimes the occurrence of
viral persistence is only made evident via a stress induced
event that likely impairs host control [63]. Whether per-
sistent IHNV in Sockeye Salmon observed herein could
be reactivated and/or disrupt host control is an important
avenue for further investigation.
Gene expression influenced by IHNV status
To explore the differences in gene expression between
those fish carrying IHNV versus those without detect-
able virus, we used the cGRASP 4x44K salmonid arrays
recently validated in Salmo salar and Oncorhynchus spp.
[40, 65], to measure whole brain transcriptional differ-
ences between these IHNV states. One of the main dif-
ferences observed between asymptomatic survivors and
carriers, is in their regulation of genes involved with
antibody production. The importance of an antibody re-
sponse in protecting salmon against IHNV has been well
demonstrated by passive immunization studies using
sera with neutralizing antibodies [66]. Several genes in-
volved in antibody production were significantly up-
regulated in the brains of carriers relative to naive fish.
Interestingly, with exception of two weakly up-regulated
probes, none of these genes were found to be differen-
tially expressed when survivors were compared to naïve
fish. As the whole brain tissue was examined it is uncer-
tain if these genes were being expressed by peripheral
leukocytes that had become associated with and/or en-
tered the brain, expressed by cells of the central nervous
system (CNS), or both. Peripheral leukocytes can be re-
cruited to, and in some cases enter and persist within,
the brain (reviewed in [67]). In response to virus infec-
tion, IgM+ lymphocytes have been reported to infiltratethe brain of gilthead seabream that was an asymptomatic
carrier of viral nervous necrosis virus (VNNV) [31]. This
observation led these authors to propose the major role
of local adaptive immunity in the control of VNNV in
this species. Whether the adaptive immune response in
Sockeye Salmon is playing a similar role in IHNV car-
riers is uncertain.
Antibodies may neutralize or opsonize a pathogen,
but may also be involved in activation of the comple-
ment system. The involvement of complement in
IHNV carriers was indicated by the up-regulation of
C1QB and C1S in carriers vs. naïve fish. These com-
plement components bind antibodies that are part of
an antibody-pathogen complex to initiate the comple-
ment cascade of the classical pathway. Noteworthy,
antibodies may prevent spread of virus and infection
of cells, but elimination of virus in already infected
cells is probably dependent on cellular immunity in-
volving cytotoxic cells. The GO enrichment identified
T cell differentiation among carrier-relevant probes in-
dicating a role of cellular immunity, although only
three probes representing two known genes were as-
sociated with this function.
Alternatively, the expression of Ig in cells of the CNS
in fish may be involved in neuroprotection and/or repair
as seen in higher vertebrates. It has been recently dem-
onstrated that immunoglobulin expression as mRNA
and/or proteins can occur in the cells of CNS of murines
and humans [68–70]. From these studies it appears that
immunoglobulins participate in other non-immune re-
lated roles within the CNS. As an example, IgG gene
and protein expression was found to be up-regulated in
primary cultures of rat neurons in response to injury due
to complement and microglial activation, suggesting a
protective role of IgG against such injuries [70]. Whether
the expression of genes related to antibody production in-
dicate that carriers are in an earlier stage of the infection
process, or whether this expression is related to neuropro-
tection remains unknown. In any case, a hallmark of
IHNV carriers was a significant increased expression of Ig
and complement system components.
Another function that was likely altered as a result of
being an IHNV carrier is antigen presentation. Up-
regulation of probes signaling an involvement of MHC
class I pathways were evident in carriers. The probe B2M
was a predominate indicator of the involvement of the
MHC class I pathway although other probes involved in
protein processing and peptide loading (i.e. PSMB6,
PSMB7 and tapasin) were also up-regulated among car-
riers. Overall the involvement of the MHC class I pathway
being exclusive to carriers is parsimonious with the pres-
ence of IHNV in brains of these fish, as a main function of
the MHC class I molecules is the presentation of intracel-
lular antigens.
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(APCs) in response to IHNV was indicated in carriers
relative to naïve fish by the up-regulation of CD74 and
CTSS, which are components of the MHC class II path-
way. However, MHC II was not differentially expressed in
carriers compared to naïve fish. For CD74, it has been as-
sumed that it is regulated similarly as MHC II, since MHC
II molecules are dependent on CD74 as a chaperon to ful-
fill their role in antigen presentation [71], and since both
genes are dependent on the same transcriptional regulator
CIITA [72]. However, a recent study found that the MHC
II and CD74 mRNA levels do not exhibit a synchronized
behavior during maturation of dendritic cells which are
one type of APCs [73]. While CD74 mRNA levels are sus-
tained, MHC II expression is down-regulated. Thus in our
study, if APCs underwent virus-induced maturation
within the brain, down-regulation of MHC II would be ex-
pected, but this may have been obscured by the infiltration
of immature APCs which express high levels of MHC II
mRNA [74].
The lysosomal cysteine protease CTSS, up-regulated in
carriers, may be involved in degradation of antigens to
present peptides on MHC class II molecules. However, in-
creased expression of CTSS as well as lysozyme was also
associated with neurodegeneration in mammals [75]. Al-
though this characteristic has yet to be demonstrated in
fish it is worth to mention that several probes annotated
as lysozyme g were significantly up-regulated in brains of
carriers and survivors compared to naïve fish.
Another key finding of this study was the down-
regulation of genes involved in the mevalonate pathway
leading to cholesterol biosynthesis in carriers and survivors
when compared to naïve individuals. Cholesterol is an es-
sential component in cellular membranes and abundantly
found in the CNS where it plays a key role in synapse for-
mation and function [76, 77]. However the cholesterol
pathway and its modulation have also been proposed as an
important antiviral mechanism. Inhibition of cholesterol
biosynthesis and cholesterol-removing agents have been
shown to impair the viral lifecycle of various viruses [46].
Moreover the down-regulation of cholesterol biosynthesis
genes has been observed in both acute and persistent viral
infections and is believed to restrict viral assembly through
reduced cholesterol reserves [48, 78]. How viruses trigger
cholesterol modulation in a host is uncertain, however
Blanc et al. [79] recently proposed that down regulation of
cholesterol-metabolic pathway is dependent upon a type I
IFN response that is initiated by a viral infection. These
authors also noted that the anti-viral effect of down-
regulating the sterol pathway was dependent on the avail-
ability of mevalonate rather than cholesterol as had been
proposed by others. In our study, the down-regulation of
genes involved in the mevalonate pathways in both IHNV
survivors and carriers suggests that this response isassociated with IHNV exposure. Nonetheless whether this
altered gene expression measured in survivors and carriers
is reflective of an antiviral response is unclear. Notably such
mevalonate pathway regulation has not been reported in
kidney or spleen tissues of salmonids with acute IHNV in-
fection, despite the strong induction of a type I IFN re-
sponse [60, 80, 81]. Here, genes related to a type I IFN
response were not up-regulated in response to being a
survivor/carrier of IHNV thus type I IFN was probably
not necessary to down-regulate the mevalonate path-
way. Whether such mevalonate modulation would be
observed in brain tissue of Sockeye Salmon during the
acute stage of infection or whether this response is re-
stricted to IHNV survivors and carriers remains unresolved
and requires further investigations.
If down regulation of cholesterol biosynthesis is suggest-
ive of an antiviral mechanism in Sockeye Salmon carriers it
is unclear why a similar response is also induced in survi-
vors. One possible explanation is that survivors may still
contain IHNV albeit at levels below our detection limit yet
sufficient enough to influence cholesterol biosynthesis. Al-
ternatively, the down-regulation of cholesterol biosynthesis
in survivors and carriers may not reflect an antiviral mech-
anism but rather suggest a cellular or metabolic change in
response to neuronal damage caused by IHNV infection.
Brain has been demonstrated as a tissue tropism for IHNV
[57, 82] however more work is required to determine
whether neuropathological changes occur due to IHNV in-
fections. With a related fish virus, VHSV, neuronal damage
was associated with infection of peripheral nerves in wild
Pacific Herring [83]. Moreover a study on the highly neuro-
tropic pathogen, rabies virus, also in the Rhabdoviridae
family, demonstrated that infection in mice can cause per-
manent neuronal damage that can persist in the absence of
sustained viral antigen and prohibit recovery to a pre-
infection phenotype [84]. Whether such sustained impacts
would occur from the neuropathogenesis of IHNV in Sock-
eye Salmon is uncertain, although it is noteworthy that the
capacity for neurogenesis and neuronal regeneration is
much greater in fish than in mammals [85]. In fact,
several differentially expressed probes suggesting func-
tions of regeneration and neurogenesis were observed
in IHNV carriers and survivors, along with forebrain
development revealed through GO enrichment of carrier-
relevant probes.
Interestingly, in the comparison of brain expression
profiles of IHNV-exposed versus naïve fish there is an
indication that IHNV exposure may also have potential
effects on host behavior. Among the carrier profiles, the
GO category behavior was enriched and EPD with a po-
tential role in behavior was significantly up-regulated in
both survivors and carriers relative to control fish. In
zebrafish, the inactivation of EPD resulted in increased
aggression and an enhanced competitive ability [86], so
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pression of EPD may exert towards behavior in Sockeye
Salmon. Virus induced behavioral changes in fish have
been largely unstudied although common carp (Cyprinus
carpio carpio) infected with cyprinid herpesvirus-3, ex-
hibited a phenomena known as behavioral fever by mi-
grating to warmer water in comparison to non-infected
control fish [87].
Gene expression influenced by poly(I:C)-injection
In an effort to better understand whether IHNV exposure
and persistence may alter the capacity of Sockeye Salmon
to respond to other viruses, we subjected IHNV carriers,
survivors and naïve fish to the viral mimic, poly(I:C). The
double-stranded RNA molecule poly(I:C) is well docu-
mented as a viral mimic in fish due to its strong induction
of a type I IFN response [88–92]. Such an elevated innate
response was corroborated in our study where Sockeye
Salmon, regardless of their IHNV status, responded to
poly(I:C)-injection with the up-regulation of a large num-
ber of probes typically found after viral infection or
poly(I:C) treatment [32, 54, 60, 93, 94].
Among the list of probes affected by poly(I:C) treat-
ment, fifteen were previously identified as differentially
expressed in the survivors and carriers as discussed
above. However for the majority of these probes (11 of
the 15) their expression was always down-regulated
when associated with poly(I:C) treatment while in survi-
vors and/or carriers (not receiving the viral mimic), the
probes were always up-regulated. This may be explained
by differences in the signaling pathways activated by
IHNV status compared to poly(I:C). Due to the ability of
the viral mimic to suppress expression of these probes,
it is possible that their putative functions as occurring in
survivors and carriers may be compromised upon subse-
quent viral challenge. Serotransferrin-2 and EPD were
among the probes identified and suggest that a viral
challenge of survivors and carriers may interfere with
processes as far reaching as neuronal recovery, behavior,
and iron homeostasis [86, 95, 96]. However it is note-
worthy that among these 11 probes which were sup-
pressed by the viral mimic, none have been identified as
virus responsive genes [54] and are likely not required
for the innate antiviral response needed to cope with a
subsequent virus challenge.
Of the remaining four probes common to both survi-
vors and carriers treated with and without poly(I:C), an
up-regulation of expression was observed regardless of
treatment. As these probes responded concordantly
across poly(I:C) and survivor/carrier groups it is likely
that they are also functioning similarly in these groups.
Two of the probes, PSMB7 and TAPBP are thought to
play a role in the MHC class I pathway and have been
previously shown to be up-regulated after IHNVstimulation [60]. Consequently, it was not unexpected
that these probes showed increased expression in
poly(I:C)-injected fish relative to non-injected fish and
their up-regulation in carriers relative to control fish
supports a hypothesis that carriers are likely mounting a
response to the detectable IHNV in their brain. Interest-
ingly, IHNV carriers did not elicit an interferon pathway
response as was observed for Atlantic cod that were
asymptomatic carriers of nodavirus [32], suggesting that
these viruses likely differ in strategy by which they per-
sist in the host.Genes influenced by poly(I:C) injection and IHNV status
interaction
Although both naïve and previously exposed fish seem
to mount a characteristic antiviral immune response to
poly(I:C), there were 162 probes with a post-poly(I:C)
expression level dependent on the IHNV status. These
probes were grouped into four clusters based on their
expression pattern, the most distinct being cluster I
(Fig. 3). This cluster contained genes involved in defense
response which were more up-regulated in survivors and
carriers than they were in naïve fish following poly(I:C)
injection.
While poly(I:C) is known to improve the immune re-
sponse when co-administered with antigens (reviewed in
[97]) in our study the delivery of antigen and poly(I:C)
occurred several months apart from each other. There-
fore, our study might be similar to a study in mice [98]
that were treated with poly(I:C) alone or in combination
with vaccinia virus vaccines three days after infection
with the ectromelia virus (ECTV) that is the causative
agent of mousepox. Interestingly, the treatment of
poly(I:C) alone resulted in prevention of mortality and re-
duced viral load in target organs. Furthermore, type I IFN
alpha sera levels were much higher in ECTV-infected and
poly(I:C)-treated than in poly(I:C)-treated naïve mice. This
boosting effect of poly(I:C) in combination with the
present ECTV antigens might be similar to our study
where the fold change of several virus responsive genes
(e.g. SACS, MX, ZNFX1, STAT1, RTP3, IFI44) was higher
in poly(I:C)-injected survivors and carriers compared to
poly(I:C)-injected naïve fish relative to their respective
non-injected controls, although the interaction effect for
these genes was not significant (p > 0.01). While other
genes had a significant interaction effect (e.g. cluster I in
Fig. 3), we cannot exclude the possibility that our ability to
detect this interaction was limited by the sample size of
carriers. However, even with higher statistical power, it will
be difficult to exclude the possibility that more Sockeye
Salmon with strong antiviral responses survived the initial
IHNV challenge than do those with weak responses and
subsequently the surviving fish are those with the
Müller et al. BMC Genomics  (2015) 16:634 Page 16 of 19strongest antiviral response whereas the naïve fish would
be a mixture of weak and strong responders.
Finally, the elevated expression after poly(I:C) injection
in survivors and carriers may have occurred due to slight
differences in cell composition in the brain resulting from
previous IHNV infection. Some cell types might respond
stronger to poly(I:C) than others, as was shown for mur-
ine macrophages and fibroblasts [99]. The present tran-
scriptome analysis suggests that immune responses as
well as regeneration and neurogenesis occur in brain of
both survivors and carriers. Whether this would change
the brain cell make-up in survivor and carriers compared
to naïve fish needs further investigations.
While the impact of such IHNV status-dependent ele-
vated expression after poly(I:C)-injection is unclear, it is
possible that fish surviving IHNV challenge may have a
facilitated response to subsequent viral challenge. Pro-
tective effects against IHNV elicited in rainbow trout
pre-exposed to avirulent reovirus have been described
[100]. Undoubtedly, further testing of this hypothesis
would hold the promise to improve our understanding
of ecological consequences of surviving a previous ex-
posure to IHNV.Conclusions
This is the first transcriptional study of IHNV persistence
in Sockeye Salmon. Fish surviving IHNV exposure
(survivors, carriers) show distinct transcriptional pro-
files in brain compared to naïve fish. Whether these
differences result in physiological, behavioral and/or
ecological consequences requires further investigation.
Furthermore, IHNV carriers show signs of an ongoing
adaptive immune response. Whether this is related to
stage of infection or maintenance of the carrier state is
currently unknown. In addition, the down-regulation
of genes related to cholesterol biosynthesis suggests an
anti-IHNV response previously undescribed in fish that
is similar to a response recently identified in higher verte-
brates. The IHNV status affected the expression of some
genes in response to poly(I:C) injection, most notably by
increasing a subset of defense-related transcripts, but
overall the characteristic antiviral response was main-
tained. Thus, we found no evidence that IHNV exposure
limits the immune response to other viral antigens (after
the acute infection stage). In summary, these data expand
upon our understanding of IHNV infections and provide
insight into the mechanism by which the virus is main-
tained in Sockeye Salmon populations.Availability of supporting data
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